Form 4: Assertio Holdings CEO Brendan O'Grady Awarded Stock Options and Restricted Stock Units
SEC Form 4
Assertio Holdings CEO Brendan O'Grady received stock options and restricted stock units as part of his compensation.
Summary
- Brendan P. O'Grady, CEO of Assertio Holdings, Inc., was granted stock options and restricted stock units on February 18, 2025.
- He received 755,525 stock options with an exercise price of $0.81, expiring on February 18, 2035.
- O'Grady also received 500,000 restricted stock units, each representing a contingent right to receive one share of Assertio's common stock.
- The stock options and restricted stock units vest in equal installments over three years from the grant date, contingent upon continued employment.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, which are generally viewed favorably as aligning management and shareholder interests.
Positives
- The grant of stock options and restricted stock units aligns the CEO's interests with those of the shareholders.
- Vesting requirements incentivize continued employment and performance.
Risks
- The value of the stock options and restricted stock units is dependent on the future performance of Assertio Holdings' stock.
- If O'Grady leaves the company before the vesting dates, he will forfeit the unvested portion of the awards.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the equity awards.
Industry Context
Equity compensation is a common practice for aligning management incentives with shareholder value in publicly traded companies.
Comparison to Industry Standards
- Equity grants to CEOs are standard practice in the pharmaceutical industry to incentivize performance and align interests with shareholders.
- The vesting schedule of one-third per year over three years is a typical vesting arrangement.
- Comparable companies like Mallinckrodt or Teva Pharmaceuticals also utilize stock options and restricted stock units as part of their executive compensation packages.
Stakeholder Impact
- Shareholders may view the equity grants positively as they incentivize the CEO to increase shareholder value.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of grant for stock options and restricted stock units. |
| 02/18/2028 | Expiration date for restricted stock units. |
| 02/18/2035 | Expiration date for stock options. |
| 02/20/2025 | Date of signature for the SEC filing. |
Keywords
stock options, restricted stock units, CEO, Brendan O'Grady, Assertio Holdings, ASRT, compensation, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.